Thrombocythemia Myelofibrosis
Showing 401 - 412 of 412
MDS, Myelofibrosis Trial in Jerusalem (DBM for creation of bone marrow microenvironment)
Withdrawn
- Myelodysplastic Syndromes
- Myelofibrosis
- DBM for creation of bone marrow microenvironment
-
Jerusalem, IsraelHadassah Medical Organization
Apr 27, 2011
Labile Plasma Iron in Myelodysplastic Syndromes and Primary
Unknown status
- Myelodysplastic Syndrome
- Primary Myelofibrosis
-
Holon,, IsraelWolfson Medical Center
Apr 7, 2011
Biological Data With Potential Prognostic Relevance in
Unknown status
- Myelodysplastic Syndrome
-
Coppito, L'Aquila, Italy
- +13 more
Feb 7, 2011
Chronic Myeloproliferative Disorders Trial in France, United Kingdom, United States (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- filgrastim
- +4 more
-
Anchorage, Alaska
- +8 more
Jun 15, 2010
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial in Seattle (busulfan,
Completed
- Chronic Myeloproliferative Disorders
- +2 more
- busulfan
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Seattle (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
May 12, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Seattle (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Seattle (beclomethasone dipropionate)
Completed
- Breast Cancer
- +11 more
- beclomethasone dipropionate
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- monoclonal antibody A27.15
- monoclonal antibody E2.3
-
Tucson, ArizonaArizona Cancer Center
Mar 12, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New Brunswick (tetradecanoylphorbol acetate)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- tetradecanoylphorbol acetate
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Jan 25, 2010
Bone Marrow Transplant Chart Review for RIC
Completed
- Myelofibrosis
- Reduced Intensity Conditioning (RIC) Allogenic Transplant
-
Houston, Texas
- +3 more
Oct 8, 2009